JP2002502243A5 - - Google Patents

Download PDF

Info

Publication number
JP2002502243A5
JP2002502243A5 JP1998550771A JP55077198A JP2002502243A5 JP 2002502243 A5 JP2002502243 A5 JP 2002502243A5 JP 1998550771 A JP1998550771 A JP 1998550771A JP 55077198 A JP55077198 A JP 55077198A JP 2002502243 A5 JP2002502243 A5 JP 2002502243A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998550771A
Other languages
English (en)
Japanese (ja)
Other versions
JP4293292B2 (ja
JP2002502243A (ja
Filing date
Publication date
Priority claimed from GBGB9711115.7A external-priority patent/GB9711115D0/en
Application filed filed Critical
Publication of JP2002502243A publication Critical patent/JP2002502243A/ja
Publication of JP2002502243A5 publication Critical patent/JP2002502243A5/ja
Application granted granted Critical
Publication of JP4293292B2 publication Critical patent/JP4293292B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP55077198A 1997-05-29 1998-05-29 トランスフェクション活性を有するインテグリン−ターゲッティングベクター Expired - Fee Related JP4293292B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9711115.7 1997-05-29
GBGB9711115.7A GB9711115D0 (en) 1997-05-29 1997-05-29 Integrin-targeting vectors having enhanced transfection activity
PCT/GB1998/001577 WO1998054347A1 (en) 1997-05-29 1998-05-29 Integrin-targeting vectors having transfection activity

Publications (3)

Publication Number Publication Date
JP2002502243A JP2002502243A (ja) 2002-01-22
JP2002502243A5 true JP2002502243A5 (https=) 2005-12-08
JP4293292B2 JP4293292B2 (ja) 2009-07-08

Family

ID=10813246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55077198A Expired - Fee Related JP4293292B2 (ja) 1997-05-29 1998-05-29 トランスフェクション活性を有するインテグリン−ターゲッティングベクター

Country Status (9)

Country Link
US (2) US6458026B1 (https=)
EP (1) EP1003898B1 (https=)
JP (1) JP4293292B2 (https=)
AT (1) ATE301722T1 (https=)
AU (1) AU7667398A (https=)
CA (1) CA2288840A1 (https=)
DE (1) DE69831156T2 (https=)
GB (1) GB9711115D0 (https=)
WO (1) WO1998054347A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1230441C (zh) 2000-04-12 2005-12-07 安盛药业有限公司 结合整联蛋白的肽衍生物
AU2001258659A1 (en) * 2000-05-30 2001-12-11 Ich Productions Limited Improved methods of transfection
EP1178117A1 (en) * 2000-08-02 2002-02-06 Erasmus Universiteit Rotterdam Targeting through integrins
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
US8613907B2 (en) * 2000-10-12 2013-12-24 University Of Rochester Compositions that inhibit proliferation of cancer cells
GB0106315D0 (en) 2001-03-14 2001-05-02 Ich Productions Ltd Transfection complexes
CA2449054C (en) * 2001-05-30 2011-01-04 The Scripps Research Institute Integrin targeting liposome for nucleic acid delivery
WO2003006491A2 (en) 2001-07-10 2003-01-23 Amersham Health As Peptide-based compounds for targeting intergin receptors
US7598421B2 (en) 2002-05-08 2009-10-06 Ucl Biomedica Plc Materials for the delivery of biologically-active material to cells
GB0210538D0 (en) * 2002-05-08 2002-06-19 Univ London Lipids and gene delivery
WO2004096140A2 (en) * 2003-04-25 2004-11-11 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
GB0313132D0 (en) * 2003-06-06 2003-07-09 Ich Productions Ltd Peptide ligands
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
EP1687017B1 (en) 2003-10-24 2013-03-06 Gencia Corporation Methods and compositions for delivering polynucleotides
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
AU2007211334A1 (en) * 2006-02-01 2007-08-09 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
US10034674B2 (en) * 2006-02-02 2018-07-31 Steven C Chudik Universal anterior cruciate ligament repair and reconstruction system
GB0610636D0 (en) * 2006-05-30 2006-07-05 Univ London Materials and complexes for the delivery of biologically-active material to cells
RU2010107199A (ru) * 2007-07-31 2011-09-10 Дзе Джонс Хопкинс Юниверсити (Us) Конъюгат полипептид-нуклеиновая кислота для иммунопрофилактики или иммунотерапии для неопластических или инфекционных нарушений
PT2252627T (pt) * 2008-01-24 2017-07-24 Esperance Pharmaceuticals Constructos de fusão de domínio lítico e métodos para produzir e utilizar os mesmos
US20110256055A1 (en) 2008-12-23 2011-10-20 Ge Healthcare Limited Application of 99mtc peptide-based compound as a bone marrow imaging agent
EP4710943A3 (en) 2015-08-28 2026-04-29 Molecular Transfer, Inc. Transfection complexes and methods of using the same
CN108779074A (zh) 2016-03-01 2018-11-09 分子传递有限公司 植物病毒移动蛋白和其使用方法
GB201604235D0 (en) 2016-03-11 2016-04-27 Ucl Business Plc Lipids and complexes for the delivery of biologically-active material to cells
GB201803419D0 (en) * 2018-03-02 2018-04-18 Ucl Business Plc Complex for the delivery of cas9 proteins guide RNA to cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981478A (en) 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
CA2204254C (en) 1994-11-17 2010-02-16 Stephen Lewis Hart Internalisation of dna, using conjugates of poly-l-lysine and an integrin receptor ligand
US5736392A (en) * 1995-06-07 1998-04-07 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
US5908777A (en) 1995-06-23 1999-06-01 University Of Pittsburgh Lipidic vector for nucleic acid delivery

Similar Documents

Publication Publication Date Title
JP2000509637A5 (https=)
JP2000509942A5 (https=)
JP2000507042A5 (https=)
JP2000510751A5 (https=)
JP2000509912A5 (https=)
JP2001523091A5 (https=)
JP2001511200A5 (https=)
JP2000507369A5 (https=)
JP2000507433A5 (https=)
JP2000510793A5 (https=)
JP2001518028A5 (https=)
JP2000508022A5 (https=)
JP2002515214A5 (https=)
JP2001522520A5 (https=)
JP2002508657A5 (https=)
JP2000508680A5 (https=)
JP2000509804A5 (https=)
JP2000509755A5 (https=)
JP2002502243A5 (https=)
JP2000510247A5 (https=)
JP2000510969A5 (https=)
JP2000508102A5 (https=)
JP2000509818A5 (https=)
JP2000507434A5 (https=)
JP2001500285A5 (https=)